Interferon-gamma (IFNG) plays a key role in immune responses in head and neck squamous cell carcinoma (HNSCC) and impacts the effectiveness of immune checkpoint inhibitors. This evidence concerns the gene IFNG and head and neck squamous cell carcinoma.